The eye-care company Alcon Research has entered into licensing ... known as POT-4 — for the treatment of age-related macular degeneration (AMD). The financial terms of the deal were not disclosed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback